. Author manuscript; available in PMC: 2021 Sep 26.

Published in final edited form as: Can J Cardiol. 2020 May 23;36(11):1722–1728. doi: 10.1016/j.cjca.2020.05.026

Table 2.

Development of incident coronary artery disease in colchicine users vs nonusers

	Colchicine (n = 446)			No colchicine (n = 276)
Event	Event rate	Events/1000 patient-years	Inverse probability weighting HR (95% CI)	Event rate	Events/1000 patient-years	Inverse probability weighting HR (95% CI)	P value
Incident stable CAD	40 (9.0%)	12.3 (9.0–16.7)	0.49 (0.23–1.05)	18 (6.5%)	11.6 (7.3–18.4)	Reference	0.24
Incident stable CAD + myocardial infarction	40 (9.0%)	12.3 (9.0–16.7)	0.37 (0.16–0.83)	19 (6.9%)	12.3 (7.9–19.2)	Reference	0.32

Data are shown as frequency (proportion) and compared using χ² test.

CAD, coronary artery disease; CI, confidence interval; HR, hazard ratio.